A Culturally Sensitive Social Support Intervention (JLA)

February 20, 2024 updated by: M.D. Anderson Cancer Center
This study is a randomized controlled trial (RCT) to assess the impact of a culturally based social support program (i.e. Joy Luck Academy, JLA) among Chinese American breast cancer survivors.

Study Overview

Status

Recruiting

Detailed Description

This study is a randomized controlled trial (RCT) to test the health benefits of an education and peer mentor support intervention. Chinese American breast cancer survivors who have completed primary treatment will be randomly assigned to either the intervention group or a control group to receive enhanced usual care while waiting for the JLA. Health outcomes are assessed at baseline, immediately post intervention, and 1 and 4 months follow-ups.

Study Type

Interventional

Enrollment (Estimated)

168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • Los Angeles, California, United States, 91776
        • Recruiting
        • Herald Cancer Association
        • Contact:
          • Alice Loh
          • Phone Number: 626-286-2600
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

  • self-identified to be comfortable speaking Chinese (Mandarin or Cantonese)
  • having a first breast cancer diagnosis of stages 0-III
  • having completed primary treatment (surgery, chemotherapy, or radiotherapy) within the last 36 months

Exclusion criteria:

  • unable to read or speak Chinese (Mandarin or Cantonese)
  • breast cancer diagnosis of stage IV
  • live outside of the LA area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Enhanced care and wait-list control group
Participants in the control group will receive enhanced usual care while waiting for the JLA program. Participants will be given information booklets in Chinese developed by the American Cancer Society and cover common issues related to breast cancer, various treatments, and life after treatment. Participants will be asked to read through the booklet individually.
Experimental: Social support intervention group
The intervention is a 7-week program includes educational and peer mentoring support components. The education curriculum provides information on recognizing side effects of treatment and differentiating them from symptoms of cancer recurrence, physical therapy and alternative treatment, stress management, recognizing depression and managing emotional problems, communication with family members, and body image. The peer-support component assigns each participant with a mentor who is a breast cancer survivor. They share their own experience with participants and also make weekly phone calls to mentees during the intervention to provide support and address remaining concerns.
The social support intervention is a 7-week program includes educational and peer mentoring support components. The education curriculum provides information on recognizing side effects of treatment and differentiating them from symptoms of cancer recurrence, physical therapy and alternative treatment, stress management, recognizing depression and managing emotional problems, communication with family members, and body image. The peer-support component assigns each participant with a mentor who is a breast cancer survivor. They share their own experience with participants and also make weekly phone calls to mentees during the intervention to provide support and address remaining concerns.
Other Names:
  • JLA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Quality of life as assessed by Functional Assessment of Cancer Therapy Scale (FACT)
Time Frame: Baseline before intervention and immediately, 1 month, and 4 months after the intervention
Baseline before intervention and immediately, 1 month, and 4 months after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in depressive symptoms as assessed by CES-D
Time Frame: Baseline before intervention and immediately, 1 month, and 4 months after the intervention
Depressive symptoms will be measured with the Chinese short-form version (Boey, 1999) of the Center for Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) as well as two additional items ("I don't want to have contact with people, socialize, or go out at all" and "I have thought about hurting myself") from the Chinese American Depression Scale (CADS-9).
Baseline before intervention and immediately, 1 month, and 4 months after the intervention
Change in positive affect as assessed by the PANAS
Time Frame: Baseline before intervention and immediately, 1 month, and 4 months after the intervention
Baseline before intervention and immediately, 1 month, and 4 months after the intervention
Change in fatigue as assessed by FACIT
Time Frame: Baseline before intervention and immediately, 1 month, and 4 months after the intervention
A short-version (i.e. 6-item) of Functional Assessment of Chronic Illness Therapy-Fatigue scale was used.
Baseline before intervention and immediately, 1 month, and 4 months after the intervention
Change in stress as assessed by the Perceived stress scale (PSS)
Time Frame: Baseline before intervention and immediately, 1 month, and 4 months after the intervention
Baseline before intervention and immediately, 1 month, and 4 months after the intervention

Other Outcome Measures

Outcome Measure
Time Frame
Change in cortisol slope
Time Frame: Baseline before intervention and immediately
Baseline before intervention and immediately

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Qian Lu, PhD; MD, University of Houston

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Estimated)

August 31, 2025

Study Completion (Estimated)

August 31, 2025

Study Registration Dates

First Submitted

October 25, 2016

First Submitted That Met QC Criteria

October 25, 2016

First Posted (Estimated)

October 27, 2016

Study Record Updates

Last Update Posted (Estimated)

February 22, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PA18-0280
  • R01CA180896 (U.S. NIH Grant/Contract)
  • 16402-02 (Other Identifier: University of Houston)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Social support intervention

3
Subscribe